Considering the importance of ATM kinase in DNA damage repair, our data suggests that activating or inactivating ATM gene polymorphisms influence the efficacy of radiation therapy and the prognosis of NSCLC patients. This evidence concerns the gene ATM and non-small cell lung carcinoma.